These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 7579381)
1. Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma. Koduru PR; Zariwala M; Soni M; Gong JZ; Xiong Y; Broome JD Blood; 1995 Oct; 86(8):2900-5. PubMed ID: 7579381 [TBL] [Abstract][Full Text] [Related]
2. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Takeuchi S; Bartram CR; Seriu T; Miller CW; Tobler A; Janssen JW; Reiter A; Ludwig WD; Zimmermann M; Schwaller J Blood; 1995 Jul; 86(2):755-60. PubMed ID: 7606004 [TBL] [Abstract][Full Text] [Related]
3. Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines. Southgate J; Proffitt J; Roberts P; Smith B; Selby P Br J Cancer; 1995 Nov; 72(5):1214-8. PubMed ID: 7577470 [TBL] [Abstract][Full Text] [Related]
4. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma. Sonoda Y; Yoshimoto T; Sekiya T Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535 [TBL] [Abstract][Full Text] [Related]
5. Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas. Gombart AF; Morosetti R; Miller CW; Said JW; Koeffler HP Blood; 1995 Aug; 86(4):1534-9. PubMed ID: 7632961 [TBL] [Abstract][Full Text] [Related]
6. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas. Tahara H; Smith AP; Gaz RD; Arnold A J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819 [TBL] [Abstract][Full Text] [Related]
7. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Ogawa S; Hangaishi A; Miyawaki S; Hirosawa S; Miura Y; Takeyama K; Kamada N; Ohtake S; Uike N; Shimazaki C Blood; 1995 Aug; 86(4):1548-56. PubMed ID: 7632963 [TBL] [Abstract][Full Text] [Related]
8. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Hatta Y; Hirama T; Miller CW; Yamada Y; Tomonaga M; Koeffler HP Blood; 1995 May; 85(10):2699-704. PubMed ID: 7742529 [TBL] [Abstract][Full Text] [Related]
9. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Drexler HG Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410 [TBL] [Abstract][Full Text] [Related]
10. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924 [TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of a family of cyclin-dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in non-small cell lung cancers. Kawamata N; Miller CW; Koeffler HP Mol Carcinog; 1995 Dec; 14(4):263-8. PubMed ID: 8519415 [TBL] [Abstract][Full Text] [Related]
12. Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias. Nakamaki T; Kawamata N; Schwaller J; Tobler A; Fey M; Pakkala S; Lee YY; Kim BK; Fukuchi K; Tsuruoka N Br J Haematol; 1995 Sep; 91(1):139-49. PubMed ID: 7577621 [TBL] [Abstract][Full Text] [Related]
13. Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519). Jadayel DM; Lukas J; Nacheva E; Bartkova J; Stranks G; De Schouwer PJ; Lens D; Bartek J; Dyer MJ; Kruger AR; Catovsky D Leukemia; 1997 Jan; 11(1):64-72. PubMed ID: 9001420 [TBL] [Abstract][Full Text] [Related]
14. Alterations of the p15, p16,and p18 genes in osteosarcoma. Miller CW; Aslo A; Campbell MJ; Kawamata N; Lampkin BC; Koeffler HP Cancer Genet Cytogenet; 1996 Feb; 86(2):136-42. PubMed ID: 8603340 [TBL] [Abstract][Full Text] [Related]
15. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Elenitoba-Johnson KS; Gascoyne RD; Lim MS; Chhanabai M; Jaffe ES; Raffeld M Blood; 1998 Jun; 91(12):4677-85. PubMed ID: 9616165 [TBL] [Abstract][Full Text] [Related]
16. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Okuda T; Shurtleff SA; Valentine MB; Raimondi SC; Head DR; Behm F; Curcio-Brint AM; Liu Q; Pui CH; Sherr CJ Blood; 1995 May; 85(9):2321-30. PubMed ID: 7727766 [TBL] [Abstract][Full Text] [Related]
17. Absence of p18 mutations or deletions in lymphoid malignancies. Otsuki T; Jaffe ES; Wellmann A; Kumar S; Condron KS; Raffeld M Leukemia; 1996 Feb; 10(2):356-60. PubMed ID: 8637248 [TBL] [Abstract][Full Text] [Related]
18. Abnormalities of p16, p15 and CDK4 genes in recurrent malignant astrocytomas. Saxena A; Robertson JT; Ali IU Oncogene; 1996 Aug; 13(3):661-4. PubMed ID: 8760309 [TBL] [Abstract][Full Text] [Related]
19. Homozygous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood. Ohnishi H; Hanada R; Horibe K; Hongo T; Kawamura M; Naritaka S; Bessho F; Yanagisawa M; Nobori T; Yamamori S; Hayashi Y Leukemia; 1996 Jul; 10(7):1104-10. PubMed ID: 8683987 [TBL] [Abstract][Full Text] [Related]
20. Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers. Rusin MR; Okamoto A; Chorazy M; Czyzewski K; Harasim J; Spillare EA; Hagiwara K; Hussain SP; Xiong Y; Demetrick DJ; Harris CC Int J Cancer; 1996 Mar; 65(6):734-9. PubMed ID: 8631583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]